SCHEMBL3013121

SCHEMBL3013121

Cc1cc(O)c(C(C)C)cc1C(C)(C)c1cc(C(C)C)c(O)cc1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.55
TRPA1 O75762 1/20 0.44
CHRM1 P11229 1/20 0.44
SLC6A2 P23975 1/20 0.44
ADRA1A P35348 1/20 0.44
HTR2B P41595 1/20 0.44
PKM P14618 4/20 0.42
CYP2D6 P10635 4/20 0.41
CYP1A2 P05177 3/20 0.41
MAPK1 P28482 2/20 0.41
ALOX15 P16050 4/20 0.41
CYP2C9 P11712 3/20 0.41
CYP2C19 P33261 3/20 0.41
TP53 P04637 3/20 0.41
MAPT P10636 5/20 0.40
KMT2A Q03164 3/20 0.40
CYP3A4 P08684 3/20 0.40
HIF1A Q16665 3/20 0.40
THRB P10828 1/20 0.40
ALDH1A1 P00352 5/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1245063 0.88 LMNA (0.55) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL28152802 0.86 LMNA (0.53) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL9351447 0.85 LMNA (0.45) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL18262815 0.82 LMNA (0.53) LMNATRPA1CHRM1SLC6A2ADRA1A
Alcohol SCHEMBL9765954 0.82 ALOX15 (0.51) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL18262905 0.82 LMNA (0.49) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL8975143 0.82 LMNA (0.49) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL14981162 0.80 LMNA (0.50) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL18262891 0.79 LMNA (0.50) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL214157 0.78 LMNA (0.68) LMNATRPA1CHRM1SLC6A2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-63303940-A None JP disclosed
EP-2188272-B1 PHENYL- AND BENZYLTHIAZOLYLPIPERAZINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES REMYND NV (BE) 2016-02-24 EP disclosed
US-8877341-B2 Polycarbonate resin and optical film using the same MITSUBISHI GAS CHEMICAL COMPANY, INC (JP) 2014-11-04 US disclosed
US-8722681-B2 N-sulfonyl thiazolylpiperazine derivatives and related N-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases NV REMYND (BE) 2014-05-13 US disclosed
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES NV REMYND (BE) 2010-08-05 US disclosed
US-20100196720-A1 POLYCARBONATE RESIN AND OPTICAL FILM USING THE SAME ABB TECHNOLOGY LTD. (CH) 2010-08-05 US disclosed
EP-2053072-A1 POLYCARBONATE RESIN AND OPTICAL FILM USING THE SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2009-04-29 EP disclosed
JP-S63303940-A PRODUCTION OF BISPHENOLS IDEMITSU KOSAN CO LTD 1988-12-12 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES SMN1; SMN2, HTT, SNCA LMNA 80/4885TRPA1 1011/4885CHRM1 4237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.